Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Emerging cell and molecular targets for treating mucus hypersecretion in asthma

Allergology International(2024)10.1016/j.alit.2024.04.002Source: DataRank Database

Emerging cell and molecular targets for treating mucus hypersecretion in asthma is a research paper published in Allergology International (2024). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 3.92)OA: goldTopics (33)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Eszter K. Vladar ORCID,Fernando Holguín ORCID,Burton F. Dickey ORCID,Christopher M. Evans ORCID,Ana M. Jaramillo ORCID

Live enrichment

PubMed:38692992 OpenAlex:https://openalex.org/W4396559899

National Institutes of Health

Grant: R01 HL166895

National Institutes of Health

Grant: R01 AI152504

National Institutes of Health

Grant: K99 HL165072

National Institutes of Health

Grant: P01 HL162607

National Institutes of Health

Grant: R01 HL130938

National Institutes of Health

Grant: R01 HL080396

National Institutes of Health

Grant: R01 HL129795

US Department of Veterans Affairs

Grant: I01 BX005343

FWCI

3.92

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.alit.2024.04.002

publisherhttps://doi.org/10.1016/j.alit.2024.04.002

publisherhttps://api.elsevier.com/content/article/PII:S1323893024000467?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1323893024000467?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38692992

Fields of Study

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisGlycosylation and Glycoproteins ResearchAsthma and respiratory diseasesHumansAsthmaMucusAnimalsMolecular Targeted TherapyMucinsMucin 5ACMucin-5BRespiratory Mucosa

MeSH Terms

AnimalsAsthmaHumansMucinsMucusRespiratory MucosaMucin-5BMucin 5ACMolecular Targeted Therapy

Keywords

MucusMucinSecretionAsthmaAirwayImmunologyInflammationMedicineBiologyPathologyInternal medicineMucous cell

Sustainable Development Goals

SDG 0: Good health and well-being